KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Candida krusei (1999)

• Candida krusei
• Candida krusei (1997)
• Candida krusei (1998)
• Candida krusei (1999)
• Candida krusei (24h)
• Candida krusei (25℃)
• Candida krusei (37℃)
• Candida krusei (48h)
• Candida krusei (ATCC 30676)
• Candida krusei (ATCC 6258)
• Candida krusei (ATCC 6458)
• Candida krusei (CBS 573)
• Candida krusei (Ck-100)
• Candida krusei (Ck-98)
• Candida krusei (CLY549)
• Candida krusei (fluconazole-resistant)
• Candida krusei (H11)
• Candida krusei (H9)
• Candida krusei (HV10)
• Candida krusei (IBA 161)
• Candida krusei (IFM 46838)
• Candida krusei (IFM 5749)
• Candida krusei (IFO 0584)
• Candida krusei (IFO 1162)
• Candida krusei (invasive candidiasis isolate)
• Candida krusei (Israel)
• Candida krusei (method : M27-A2-AM3 + 24h)
• Candida krusei (method : M27-A2-AM3 + 48h)
• Candida krusei (method : SYO + 24h)
• Candida krusei (method : SYO + 48h)
• Candida krusei (patient isolate)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8